Thoracic Oncology 2019
Cart 0

iStock-961295726.jpg
 

Thoracic Oncology 2019 focuses on the future of integrated practice for non-small cell lung cancer with a superb international faculty delivering short presentations with interactive audience participation.

Click here to reserve your place!

Endorsed by:

Limited tickets sponsor:

Supported by:

IASLC-Logos-HZ-tag (2).png
medela-logo-vector.png
AME logo.jpg

main sponsors:

Arthrex.png
astrazeneca.png
Medtronic.png
JandJ.png
 

28-29 November 2019

Millennium Gloucester Hotel, London, united kingdom

Picture1.jpg

Royal College of Physicians London approved 11 continuing professional development (CPD) points.

Blank.jpg
 

28 November 2019 (Day 1)

Future of early disease identification

11:00 Overview of lung cancer screening - Harry de Koning, Erasmus MC, Netherlands

11:10 Radiologic diagnosis of lung cancer - Anand Deveraj, Royal Brompton Hospital, London

11:20 Pre-operative biopsy and localisation techniques - Simon Padley, Royal Brompton Hospital, London

11:30 Operative biopsy and localisation techniques - Calvin Ng, Prince of Wales Hospital, Hong Kong

Future of locally ablative treatments (I)

12:00 Overview of sub-solid lesions - TBC

12:10 Surveillance versus resection - Dominique Gossot, Institut du Thorax Curie-Montsouris, Paris

12:20 Local versus anatomic resection - Hiaso Asamura, Keio University School of Medicine, Tokyo

13:00 Lunch

Future of locally ablative treatments (II)

14:00 Novel techniques for lung cancer resection - Joel Dunning, South Tees Hospital, Middlesborough

14:10 Single port surgery - Alan Sihoe, The University of Hong Kong Shenzhen Hospital, Hong Kong

14:20 Robotic surgery - Giulia Veronese, Humanitas Research Hospital, Milan

Future of locally ablative treatments (III)

15:00 Overview of SABR versus surgery trials - Kevin Franks - Consultant Clinical Oncologist, Leeds Teaching Hospitals NHS Trust, Leeds

15:10 SABR for "low risk" NSCLC - Suresh Senan, Amsterdam University Medical Center, Amsterdam

15:20 SABR for "high risk" NSCLC - Hiran (Chrish) Fernando, Inova Fairfax Medical Campus, Virginia Commonwealth University, Virginia

Future of locally ablative treatments (IV)

16:30 MR Linac & proton beam therapy - Corinne Faivre-Finn, Christie Hospital, Manchester

16:40 ENB guided local ablation - Calvin Ng, Prince of Wales Hospital, Hong Kong

16:50 Radiofrequency ablation - Simon Padley, Royal Brompton Hospital, London

18:00 Surgery, Statistics and Science

Inaugural Lecture by Professor Eric Lim, Imperial College London

29 November 2019 (Day 2)

Integrated care of early stage NSCLC

09:00 Surgery and chemotherapy - David Gilligan, Addenbrookes Hospital, Cambridge

09:10 Surgery and radiotherapy - Ceclie Le Pechoux, Institut Gustave Roussy, Paris

09:40 Surgery and adjuvant molecular targeted treatment - Wu Yi Long, Guangdong General Hospital, Guang Zhou

09:40 Surgery and adjuvant immunotherapy - Mary O'Brien, Royal Marsden Hospital, London

09:40 Neo-adjuvant immunotherapy and surgery - Valerie Rusch, Memorial Sloan Kettering Cancer Center, New York

09:50 Primary immnotherapy - Enriqueta Felip, Vall d'Hebron Institute of Oncology, Barcelona

Integrated care of stage III NSCLC

11:00 Surgery and chemotherapy - Eric Lim, Royal Brompton Hospital, London

11:10 Radiotherapy and immunotherapy - Corinne Faivre-Finn, Christie Hospital, Manchester

11:20 Chemotherapy and immunotherapy - Martin Reck, Lung Clinic Grosshansdorf, Grosshansdorf

Integrated care of advanced NSCLC

13:00 Molecular targeted treatment in the era of immuno-oncology - Tony Mok, Chinese University of Hong Kong, Hong Kong

13:10 Immunotherapy - Martin Reck, Lung Clinic Grosshansdorf, Grosshansdorf

13:20 Chemotherapy with immunotherapy - Enriqueta Felip, all d'Hebron Institute of Oncology, Barcelona

Integrated care of “oligometastatic” NSCLC

14:00 Radiotherapy and chemotherapy - Suresh Senan, Amsterdam University Medical Center, Amsterdam

14:10 Radiotherapy and immunotherapy - David Palma, London Health Sciences Centre, Ontario

14:20 Surgery and immunotherapy - Eric Lim, Royal Brompton Hospital, London

Novel approaches to advanced disease

15:30 Population approach to personalised molecular targeted therapy - Sanjay Popat, Royal Marsden Hospital, London

15:40 Adoptive T cell therapy for lung cancer - Alastair Greystoke, Newcastle University, Newcastle upon Tyne

15:50 New immunotherapeutic approaches for lung cancer - Sergio Quezada, University College London, London

16:30 Close of meeting

 
171717.jpg
 

conference Venue

Millennium Gloucester Hotel

4 Harrington Gardens

London SW7 4LH

 

Dates

Thu 28 November 2019 (11:00 am to 5:20 pm)

Fri 29 November 2019 (9:00 am to 4:30 pm)